Regatta Capital Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Regatta Capital Group's ABBV Position: Q2 2026 in Review
Regatta Capital Group sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 10,452 shares — an estimated $2.27M sold.
Regatta Capital Group first reported a position in ABBV in Q4 2021 and held it in 18 quarters. The position peaked at $2.57M in Q3 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Regatta Capital Group reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
- Regatta Capital Group sold 10,452 AbbVie shares in Q2 2026, an estimated $2.27M.
- Regatta Capital Group first reported a position in AbbVie in Q4 2021 and held it in 18 quarters.
- Regatta Capital Group's AbbVie position peaked at $2.57M in Q3 2025.
- 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Regatta Capital Group's 13F filing for Q2 2026, filed 12 Aug 2026.